Loads of individual commonly used analgesics (ibuprofen, diclofenac), antibiotics (sulfamethoxazole, trimethoprim), β-blockers (atenolol, metoprolol, sotalol, propranolol) and neuroleptics (carbamazepine, citalopram) to a large-scale operating wastewater treatment plant (WWTP) in Sweden (Ryaverket) were studied by monitoring concentrations and flows during a 9-year period (2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015). Variations in loads due to sampling and possible errors in chemical analyses were estimated to be below 40%. The variations in loads were analyzed and discussed in terms of the design of collecting wastewater system as an integrated part of the water treatment at the WWTP as well as the prescription and use of individual pharmaceuticals. Trend analysis in daily loads of individual pharmaceuticals indicated an increase for diclofenac, no significant changes for ibuprofen and metoprolol and a decrease for the other pharmaceuticals. The latter was ascribed to a decrease in their prescription and use. The increase in loads of diclofenac was ascribed to its growing topical use not requiring prescription. In view of future regulations by the EU, growing loads of diclofenac to WWTPs and its low removal rates in WWTPs may require an upgrade of WWTPs to achieve quality standards for diclofenac in receiving waters.
INTRODUCTION
Wastewater treatment plants (WWTPs) are regarded as the largest point sources for the release of pharmaceuticals to the aquatic environment. Most of the published studies associated with WWTPs and pharmaceuticals are dealing with the fate and/or removal of pharmaceuticals in WWTPs; additional or new processes to decrease the release of pharmaceuticals with effluent are based on a relatively short-term sampling time, although discrepant seasonal variations in the concentrations of pharmaceuticals have also been reported (Vieno et al. ; Sui et al. ) . The aim of the present work was to investigate loads of individual pharmaceuticals to a large-scale WWTP, their temporal variations and trends in loads. The study was performed at Ryaverket WWTP, representing large-scale operating WWTPs in Sweden, and the data were collected between 2006 and 2015. Chemical analysis of the influent from the WWPT was performed by three different laboratories, each with its own set of pharmaceuticals. The choice of pharmaceuticals to study was therefore limited by the possibility of finding the same pharmaceutical analyzed by all three laboratories. The individual pharmaceuticals that fulfilled these criteria were two non-steroidal anti-inflammatory drugs (ibuprofen and diclofenac), several β-blockers (atenolol, metoprolol, sotalol, propranolol) , an anti-epileptic drug (carbamazepine), two antibiotics (sulfamethoxazole and trimethoprim) and one antidepressant (citalopram). All these pharmaceuticals are both commonly used and commonly detected in the wastewater (Gros et industries, hospitals and large industries. Wastewater is collected from the catchment area of 240 km 2 Water treatment includes primary settling, chemical removal of phosphorus, activated sludge and biological nitrogen removal; the effluent is discharged to the Göta River estuary and further to Kattegat strait. Due to the climate (high precipitation), the state and age of the sewers, high proportion of combined sewer system in total and city planning (runoff from hard surfaces), the annual hydraulic load is characterized by a high segment of storm water (>50%) in relation to the sanitary one (ca. 30-40%). For example, in 2014, 3% of the hydraulic load came from ground water infiltration, 9% from industry, hospitals and other businesses, 29% from households and 59% from storm water and surface runoff. The sewer and tunnel system encompasses tunnels (total length ca. 132 km, total volume of 1 Mm 3 , cross-sectional area 6-24 m 2 , slope 0.07-0.1%) and ca. 25,000 km sewers with >230 wastewater pump stations; the transport time at dry weather flow (below 3 m 3 × s À1 ) is 16-20 h. From the inlet pump sump, the wastewater is pumped to the influent canal of the WWTP using four variable capacity wastewater lift pumps (lift height of 19 m). The flow to the canal is measured with less than 5% error. In terms of influent pumping (pumping rate to the canal or influent flow to the WWTP), the WWTP operation is integrated with the tunnel system: based on flow forecasts, the pumping rate is adjusted by operators to maintain a constant level in the WWTP pump wet well (and in the downstream part of the tunnel system). On occasions of high flows, the tunnel system (storage capacity up to 250,000 m 3 ) is used for storage of the excessive volume of wastewater. During severe storm water conditions, when the hydraulic load exceeds pumping capacity for one of the five largest sewer pump stations, the excess of untreated wastewater is discharged to receiving waters (totally 200,000 m 3 or ca. 0.4% of all wastewater from households, industry, hospitals and other businesses for 2014).
Sampling
Daily flow-proportional (pumping rate to the canal) samples of the influent were collected over 24 h by a fixed-site sampler, model Maxx SP II (Mess-u. Probenahmetechnik GmbH, Germany) routinely used for monitoring and control of sewage. Monthly samples were prepared by adding aliquots from daily samples to high density polypropylene jerry cans (2.5 L) kept in a freezer. In practical terms, to maintain the volume of monthly samples below 2.5 L, the volume (V) of any added aliquot was calculated to be equal:
where F (m 3 × s À1 ) is the average flow during the sampling period and N is the number of sampling days. The monthly samples were kept frozen at À18 W C before transport (if any) and analysis.
Chemical analysis
Analysis (gas chromatography mass spectrometry (GC-MS) or high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)) was performed by three different laboratories, as indicated in 
RESULTS AND DISCUSSION
Daily loads to the WWTP were calculated from the measured concentrations and flows and additionally normalized to loads of pharmaceuticals per person and day. The results, together with data for the population served by the WWTP and flows, are given in Table 1 .
Estimation of errors in measurements
The results are based on two primary measurements -flows and concentrations. Regarding flow measurements, the expected errors are, as mentioned earlier, below 5%. Two sources of possible uncertainties in the measured concentrations in the samples are associated with sample management, in the first place long-term storage, and errors in chemical analysis by different laboratories. Under normal conditions of keeping samples frozen, the storage is assumed to have no or low impact on the concentrations of the studied pharmaceuticals. One outlier, ibuprofen (no. 25, Table 1) , might, however, be associated with storage. The unreasonably low measured concentration (especially checked, repeated analyses) might be caused by biodegradation of easily biodegradable ibuprofen due to a temperature rise in the freezer containing this sample (an accidental stop for several days just before shipping it for analysis). No deviations in concentrations of other pharmaceuticals (not easily biodegradable) in the same sample could be found.
Regarding the agreement between the results obtained from different laboratories, a round-robin test (Paxéus ) for several pharmaceuticals covered in the present study provided data on expected levels of variations. Expressed as a ratio of confidence to average in % (confidence interval of 95%), the variations in the results are expected to be random and within 10% (metoprolol), 13% (carbamazepine), 17-23% (ibuprofen, diclofenac, trimethoprim, atenolol) and 33% (citalopram). From the above, the expected level of variations for the calculated loads from measurements of flow and chemical analysis is thus estimated to be lower than 40%.
Variations in loads with flow and served population
Temporal variations in the loads of the pharmaceuticals (g ×d À1 for the respective month) within the same year are characterized by a high degree of scattering, on average 2-3 times (the ratio between maximum and minimum values), for a period between 2006 and 2014 and are generally lower in 2013 and 2014. The highest annual variations observed in 2006, 2008 and 2011 are caused by much lower loads at higher flows. Additional examination of mass loads of pharmaceuticals normalized by excluding the population factor (loads in mg ×p À1 × d À1 ) revealed their dependence on the hydraulic load under certain conditions. As illustrated in Figure 1 (c) (metoprolol as an example), the data exhibit scattering with no dependence (no trends) in loads within the range of flows below ca. 5.2 m 3 × s À1 . Adding data for loads above 5.2 m 3 × s À1 to this set resulted in a declining trend. Such a trend was observed for all studied pharmaceuticals. In another words, it appears to be a 'loss' in the amount of pharmaceuticals (calculated loads) when hydraulic loads to the sewer are too high. Most likely the explanation of this finding is a combination of several events linked to the operative management of collecting and treating wastewater under high-flow conditions. The flow-proportional sampling is designed to measure flows pumped to the WWTP, and under normal flow conditions the daily volumes of wastewater pumped to the WWTP for treatment correspond to daily volumes of wastewater discharged to the sewer. Daily loads of pharmaceuticals to the WWTP, calculated as above from measured concentrations and flows, correspond, or are equal, to daily discharges to the sewer. The situation becomes different under wet weather conditions and combined sewer overflow. Sewer overflow results in discharges of untreated wastewater from the sewer. Although losses of pharmaceuticals associated with such discharges are very low on an annual basis, they might be significant for shorter periods, like days or weeks. High inflow of storm water brings about high dilution rates and consequently substantially lower concentrations of pharmaceuticals in the wastewater. In addition, wet weather high flows make the total daily inflow to the sewer often exceed the upper limit in the hydraulic load capacity of the WWTP. Thus, a combination of dilution and daily volumes of wastewater pumped to the WWTP below the total daily inflow to the sewer results in lower daily loads of pharmaceuticals to the WWTP (at high flows) in comparison to their daily discharges to the sewer (or daily loads to WWTP under normal flow conditions). In this respect, there appears to be a resemblance in the loading pattern between pharmaceuticals and loads of nutrients (Figure 1(d) ). It should be mentioned that the values of apparently lower loads caused by high flows did not influence the general picture of trends in loads of pharmaceuticals discussed below. Regarding the impact of the ).
population factor, under the conditions of continuous and unaffected (same rate) consumption of pharmaceuticals, an increase in the daily loads to the WWTP would be expected due to the population growing from 628,373 (2006) to 725,617 (2015) . However, such an increase in loads (g × d À1 ) is observed only for diclofenac (Figure 1(b) ). While ibuprofen and metoprolol tend to remain on the same level (Figure 1(a) ), the other pharmaceuticals show a decrease in their daily loads to the WWTP with a growing population.
Trends in loads
Among factors affecting daily loads of pharmaceuticals to the WWTP, the discharge of pharmaceuticals (pattern of use, prescriptions) is the most significant one. Therefore, trends are discussed in the present study in terms of trends in calculated daily loads per person. For two studied antibiotics, trimethoprim and sulfamethoxazole, a significant decrease in their loads is observed (Figure 2(a) and 2(b) ). Both antibiotics are used in treating a wide range of infections (urinary tract infections, methicillin-resistant Staphylococcus aureus skin infections, respiratory tract infections) and in many medications are present as a combination of both substancesso-called co-trimoxazole (ratio trimethoprim to sulfamethoxazole 0.2). In the wastewater, a strong correlation between trimethoprim and sulfamethoxazole (fractions not metabolized but excreted from patients to the sewer in unchanged form) is also observed (Figure 2(c) ) with a ratio of trimethoprim to sulfamethoxazole of 1.8. There is generally a restrictive approach to limit the use of antibiotics in Sweden (Struwe ) . A decrease in the loads of the studied antibiotics is seen as the result of the recommendations of the 'Swedish Strategic Program for Rational Use of Antimicrobial Agents and Surveillance of Resistance' (Strama) targeting the problem of bacterial resistance to antibiotics. The program started as a non-governmental organization in the mid-1990s as a reaction by physicians to upsurge in antibiotic-resistant pneumococci, later received a remit from the government, and since 2010 has been an advisory board to the Public Health Agency of Sweden. Another class of pharmaceuticals studied, so-called β-blockers, consists of atenolol, metoprolol, sotalol and propranolol, which are used to treat cardiac arrhythmias and primary hypertension. In comparison with antibiotics used temporarily, β-blockers are used for long-term treatment (months, even years). Nonselective propranolol was the first β-blocker developed to treat high blood pressure and had quite a number of serious side effects. The decrease in load of propranolol (Figure 2(d) ) can be explained by a general decline in its prescription and by a replacement by other, more modern, more selective β-blockers. Another β-blocker, atenolol, originally developed as a replacement for propranolol in the treatment of hypertension, also shows a decrease in its loads to the WWTP (Figure 2(e) ). Such a decline might depend on extra precautions in prescription of atenolol for treatment of hypertension associated with recently discovered higher risks of atenolol in provoking type-2 diabetes. Loads of metoprolol, one of the most widely sold preparations in Sweden, exhibit a very high degree of scattering and a trend to decline (Figure 2(f) ); the trend is, however, very weak. To the best of our knowledge, there are no particular restrictions in Sweden regarding the prescription of metoprolol due to its side effects. It is possible that a decline in the consumption of metoprolol and consequently its lower loads to the WWTP might be a result of the response of the medical community to recommendations of the Expert Council for Cardiovascular Diseases (Stockholm, Sweden) to use other pharmaceuticals than metoprolol as the first choice in the treatment of hypertension.
An antidepressant, citalopram, investigated in the present study belongs to the class of selective serotonin reuptake inhibitors. The decrease in the loads of citalopram as can be seen from Figure 2 (e) is continuous and may be associated with both its declining sales since the beginning of 2000 and the introduction of more potent medication containing more active ingredient (S-citalopram) but less citalopram in total. Another neuroleptic in the present study, carbamazepine, is used in Sweden primarily in the treatment of epilepsy, neuropathic pain, trigeminal neuralgia and alcohol withdrawal syndrome. The loads of carbamazepine (Figure 2 In contrast to the pharmaceuticals above requiring prescriptions, several formulations of ibuprofen and diclofenac can be used without prescription. In addition, since 2009 the availability of these pharmaceuticals has been increased, and their non-prescription formulations are sold nowadays in food stores, supermarkets etc. As can be seen from Figure 2 (i), daily loads of ibuprofen per person appear to remain unchanged. Loads of diclofenac to the WWTP, on the other hand, show a trend to increase (Figure 2(j) ). Regarding diclofenac, there are general recommendations to the medical community in Sweden to be cautious with prescriptions of diclofenac (oral use), mainly due to its side effects. However, in contrast to ibuprofen (oral use only), there is extensive topical use of diclofenac (skin patches, creams etc.) not requiring any prescription. Advertising campaigns in mass media for skin patches and creams during recent years seem to contribute to the increase of its topical use and consequently to its loads to the WWTP.
Removal of pharmaceuticals during sewage treatment (biological treatment using activated sludge) varies for For Swedish full-scale operating WWTPs, the removal efficiency of diclofenac is reported on average to be 10-20%, while metoprolol, propranolol, carbamazepine and citalopram appear not to be removed at all (Falås et al. ) .
At present in Sweden or in the EU there are no legal requirements for removal of pharmaceuticals or other organic micro-pollutants by WWTPs. Switzerland, as the first country in Europe, changed its water law in 2014, targeting 80% removal of micro-pollutants including pharmaceuticals, in the upgraded WWTPs. The upgrade techniques include ozonation of effluents and/or powder activated carbon and granular activated carbon filtration. In the future, restrictions on the discharge of micropollutants from WWTPs might be expected even in the EU. So far, the EU Water Framework Directive and Commission Implementing Decision (EU) 2015/495 has established a watch list of substances for Union-wide monitoring in the aquatic environment to set up quality standards. Among pharmaceuticals from the present study, only diclofenac is on the watch list. In view of EU coming regulations of diclofenac in receiving waters (and thus even discharges from WWTPs), its extensive and growing use, together with its low removal rate in WWTPs in Sweden, may be a warning flag for the Swedish WWTPs. The recalcitrant nature of diclofenac and its insignificant removal in conventional WWTPs using activated sludge will require upgrade of WWTPs to achieve its efficient elimination from wastewater. Such upgrade may include the use of extended biological treatment by membrane bioreactors (Cherik et al. ) and/or physicochemical processes (Beltrán et al. ) like treatment with ozone or adsorption on activated carbon.
CONCLUSIONS
Temporal variations in the loads of the pharmaceuticals to a large-scale WWTP were studied for commonly used pharmaceuticals: ibuprofen, diclofenac, atenolol, metoprolol, sotalol, propranolol, carbamazepine, citalopram, sulfamethoxazole and trimethoprim. Apparently lower daily loads of pharmaceuticals to the WWTP observed for periods of high hydraulic load to the sewer were ascribed to the integrated set-up of the WWTP operation and the tunnel system. The declining trend in daily loads per person for atenolol, metoprolol, propranolol, carbamazepine, citalopram, sulfamethoxazole and trimethoprim was assigned to their decreased prescription and use. Daily loads of ibuprofen seem to remain unchanged, while loads of diclofenac are found to increase. The latter was ascribed to the extensive non-oral use of diclofenac. In view of low removal rates of diclofenac in WWTPs and its future regulation by the EU, an upgrade of WWTPs in Sweden may be required to achieve quality standards for diclofenac in receiving waters.
